About us
Data-driven analytics for the development of tomorrow's RNA medicines
Eclipsebio's foundation is our portfolio of next-generation assays and analyses, tailored for the development of RNA-based and RNA-targeting medicines. From revealing how LNP formulations affect structure and the shelf life of RNA vaccines to identifying optimal targets for siRNAs, we provide the multiomic insights our partners need for successful drug development. Discover how our comprehensive support can make the difference between clinical trial success and failure.
Drug development enabled by data, not predictions
With our unique collection of patented next-generation sequencing assays and bioinformatics workflows, we provide actionable insights that are unavailable from any other technology or solutions provider. Our mission is to provide biopharma and biotechs with data-driven support for effective drug discovery and development, not black box predictions or incomplete data from antiquated assays. Our approach is supported by over 30 publications, partnerships with over 15 major biopharma, and collaborations with over 40 biotechs.
Precision optimization and comprehensive characterization of RNA therapeutics
Unparalleled insights into RNA targets for small molecule and RNAi development
Innovative technologies for mechanistic insights into RNA biology
Learn more
about Eclipsebio
Meet our leadership team
Our team of RNA experts is skilled in solving the major challenges for drug development and research. Learn more about our leadership and advisory board here.
Catch up on our latest news
At Eclipsebio we are continuously innovating to provide groundbreaking insights for our partners. Learn about the latest updates on our capabilities and other developments here.
Explore our events
Our team of RNA experts is frequently presenting about our cutting-edge solutions at conferences and webinars. Discover where we will be next.